Stem cell injection aims to prevent deadly liver complication
NCT ID NCT07276568
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests whether injecting special liver-like cells into the abdominal muscle can help prevent or treat Small-for-Size syndrome, a serious complication that can occur after partial liver surgery. The study involves 12 patients and focuses mainly on safety, checking for side effects and changes in liver function. If the approach proves safe, it may pave the way for larger studies to see if it truly improves outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hepatocyte-like cells (derived from induced pluripotent stem cells)
- What this could lead to
- If successful, this could lead to a new way to prevent or treat Small-for-Size syndrome, a serious complication after liver surgery, potentially improving survival.
- What could go wrong
- This is a very early (Phase 1) trial with only 12 participants, so safety and effectiveness are not yet proven. There is a risk of injection-related side effects or the cells not working as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Province, 100050, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antioxidant rescue failing livers?
- Better crystal ball for liver crisis: new scores put to the test
- Scientists hunt for clues in body fluids to predict liver failure outcomes
- Liver failure treatment MARS: does it help avoid transplants?
- New liver support protocol could help patients avoid transplant
- Massive european study aims to redefine success in liver transplants